Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

269
Delayed Quote. Delayed BATS Europe - 07/01 11:29:59 am
369.45 DKK   +1.33%
11:44aDJNovo Nordisk to Stop Selling Key Insulin Drug in Germany
09:24a NOVO NORDISK A/ : Status regarding Novo Nordisk's holding of its own..
08:34a NOVO NORDISK A/ : A/S : - Share repurchase programme
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
02:34p NOVO NORDISK A/S : Patent Issued for Therapeutic Factor VIII Antibodies
01:10p NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Obesity Reported (I..
01:09p NOVO NORDISK A/S : New Diabetes Study Findings Recently Were Reported by Researc..
11:44aDJNovo Nordisk to Stop Selling Key Insulin Drug in Germany
09:24a NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (30..
08:34a NOVO NORDISK A/S : A/S : - Share repurchase programme
06/30 NOVO NORDISK A/S : Closing the Gap Between Production and Patient
06/26 NOVO NORDISK A/S : Levemir® receives positive CHMP opinion for extended use in c..
06/26 Cinven agrees to buy majority stake in German Synlab
06/24 NOVO NORDISK A/S : Findings from Novo Nordisk Yields New Data on Proinsulin (Inv..
06/24 NOVO NORDISK A/S : Patent Issued for Method for Making Mature Insulin Polypeptid..
06/24 NOVO NORDISK A/S : Collaboration As The Means To The End
06/24 NOVO NORDISK A/S : In a phase 3 trial, NovoEight® provided long-term efficacy an..
06/24 NOVO NORDISK A/S : Fase 3-studie med NovoEight® viser langvarig effekt og sikker..
06/24 NOVO NORDISK A/S : New Novo Nordisk Data Demonstrate Caregiver Burden and Preval..
06/23 NOVO NORDISK A/S : Share repurchase programme
06/22 NOVO NORDISK A/S : Aktietilbagekøbsprogram
06/22 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/17 NOVO NORDISK A/S : Findings in the Area of Obesity and Diabetes Reported from No..
06/17 NOVO NORDISK A/S : The Results are in… Team Novo Nordisk caps off another..
06/15 NOVO NORDISK A/S : Share repurchase programme
06/15 NOVO NORDISK A/S : Three Years in a Row: Novo Nordisk In Turkey Recognised for E..
06/15 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/09 NOVO NORDISK A/S : #15 on Top Green Companies in the World
06/08 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/08 NOVO NORDISK A/S : New study with Victoza® (liraglutide) showed improvements in ..
06/08 NOVO NORDISK A/S : Nyt fase 3b-studie med Xultophy® (IDegLira) viser statistisk ..
06/08 NOVO NORDISK A/S : Share repurchase programme
06/07 NOVO NORDISK A/S : New Xultophy® (IDegLira) Phase 3b Study Showed Statistically ..
06/03 NOVO NORDISK A/S : in the US – Teaming Up to Change Diabetes
06/03 NOVO NORDISK A/S : $532.61 Million Federal Contract Awarded to Novo Nordisk
06/01 NOVO NORDISK A/S : CONTRACT AWARD - 65-- Human Insulin Novo Nordisk, Inc. July 1..
06/01 NOVO NORDISK A/S : A/S : - Share repurchase programme
06/01 NOVO NORDISK A/S : Share repurchase programme
05/27 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Ulcerativ..
05/27 NOVO NORDISK A/S : Patent Issued for Insulins with an Acyl Moiety Comprising Rep..
05/27 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Findings in Proinsulin (..
05/27 EXCLUSIVE : Greece owes drugmakers $1.2 billion - and counting
05/22 NOVO NORDISK A/S : Treatment with Saxenda® for three years reduced the risk of d..
05/22 NOVO NORDISK A/S : Behandling med Saxenda® i tre år nedsætter risikoen for at ud..
05/22DJNOVO NORDISK A/S : Hails Success in Diabetes Drug Trial
05/21 NOVO NORDISK A/S : Share repurchase programme
05/20DJNOVO NORDISK A/S : Signs Autoimmune Disease License Agreement with Janssen
05/20 NOVO NORDISK A/S : A/S : - Share repurchase programme
05/20 NOVO NORDISK A/S : Baxter clash over hemophilia drug patent
05/16 EMISPHERE TECHNOLOGIES : Reports First Quarter 2015 Financial Results
05/15 NOVO NORDISK A/S : Patent Issued for Injection Device
05/15 EMISPHERE TECHNOLOGIES : Reports First Quarter 2015 Financial Results
05/13 NOVO NORDISK A/S : NNIT A/S: 15/2015 Financial report for Q1 2015
05/11 NOVO NORDISK A/S : A/S : - Share repurchase programme
05/11 NOVO NORDISK A/S : Share repurchase programme
05/09 NOVO NORDISK A/S : Renews Commitment to World's First All-Diabetes Professional ..
05/07 NOVO NORDISK A/S : Renews Commitment to World's First All-Diabetes Professional ..
05/06 NOVO NORDISK A/S : Patent Issued for Conjugated FVIII Variants
05/06 NOVO NORDISK A/S : Findings from Novo Nordisk Provide New Insights into Oral Con..
05/06DJLundbeck Names New CEO After 1Q Net Loss
05/05 NOVO NORDISK A/S : Personalized, Patient-Centered Care Offers Best Future for Di..
05/05 NOVO NORDISK A/S : Personalized, Patient-Centered Care Offers Best Future for Di..
05/04 NOVO NORDISK A/S : Diabetic cycling team ready for Amgen Tour of California
05/04 NOVO NORDISK A/S : Clayton seeks wider planning authority
05/04DJNOVO NORDISK A/S : Invests DKK1.5 Billion in New Manufacturing Facility in Denma..
05/04 NOVO NORDISK A/S : invests DKK 1.5 billion in new haemophilia treatment manufact..
05/02 NOVO NORDISK A/S : increased operating profit in Danish kroner by 73% in the fir..
04/30DJADR Shares End Lower; Baidu, Nokia Fall
04/30 NOVO NORDISK A/S : Total number of voting rights and share capital in Novo Nordi..
04/30 NOVO NORDISK A/S : Share repurchase programme
04/30 Binge eating drug helps Shire deliver first-quarter earnings beat
04/30DJNovo Nordisk Records Growth in Net Profit -- Update
04/30DJNOVO NORDISK A/S : Records Growth in Net Profit as Diabetes Drugs Perform Well
04/30 NOVO NORDISK A/S : increased operating profit in Danish kroner by 73% in the fir..
04/30 NOVO NORDISK A/S : Increased operating profit in Danish kroner by 73% in the fir..
04/29 NOVO NORDISK A/S : Patent Issued for Acylated Exendin-4 Compounds
04/29 NOVO NORDISK A/S : announces Saxenda® liraglutide injection is now commercially ..
04/29 NOVO NORDISK A/S : Total number of voting rights and share capital in Novo Nordi..
04/29 NOVO NORDISK A/S : A/S : - Share repurchase programme
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials